Those who rely on EpiPens during an allergic reaction may have a new alternative to reach for, after the U.S. Food and Drug Administration (FDA) approved Neffy, a needle-free epinephrine product.

The FDA announced a nationwide EpiPen shortage, worrying people with severe allergies Julie Mazziotta is the Senior Sports Editor at PEOPLE, covering everything from the NFL to tennis to Simone ...

Viatris Inc., formerly called Mylan, settled a class action lawsuit alleging that they were in a scheme to monopolize the market for the life-saving medication Julie Mazziotta is the Senior Sports ...

At first, I tried to bring about a socialist paradise by reducing the price of the EpiPen to $0. This meant I was bringing in no money and my investors were none too pleased. That approach went ...

Sanofi claims its Auvi-Q, a more portable epinephrine autoinjector with a retractable needle and audio instructions, couldn't compete on the unlevel playing field Mylan created for its EpiPen. (CN) — ...